BRKR(Bruker Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $2.42B | $2.53B | $2.96B | $3.37B | $3.44B |
| 毛利润 | $1.21B | $1.31B | $1.51B | $1.65B | $1.58B |
| 营业利润 | $413.30M | $432.70M | $436.90M | $253.10M | $68.20M |
| 净利润 | $277.10M | $296.60M | $427.20M | $113.10M | −$8.60M |
| 经营现金流 | $282.40M | $274.40M | $350.10M | $251.30M | $134.10M |
| 自由现金流 | $190.40M | $145.20M | $243.20M | $136.00M | $43.30M |
| 摊薄每股收益 | $1.81 | $1.99 | $2.90 | $0.76 | $-0.15 |